Drug Companies worldwide have defined programs to collect reports of side effects and potential hazards of marketed preparations even after the drug is approved by FDA and launched. This helps the Regulatory Agencies and the Drug company to evaluate the risk:benefit profile of drugs in the market. Sometimes, compelling evidence can make the manufacturer withdraw the drug from the market or at least introduce contra-indications to prevent usage by certain high-risk group patients. This is called “Pharmacovigilance”.

However, a similar concept is largely lacking in Nutraceutical Industry. The US FDA’s Center For Food Safety and Applied Nutrition (CFSAN) and the US Federal Trade Commission (FTC) have provision for reporting side effects or complaints about misleading claims by Supplement companies. If you are from the US you may visit the following links but also report the same in the form given below. Consumers and Industry from other countries are encouraged to actively report malpractices and unsatisfactory quality of dietary supplements.

Please provide your contact details so that we may be able to reach you with our own comments, queries or answers from the manufacturer. Some manufacturers may wish to compensate you suitably for your valuable feedback.

© 2006 Vedic Lifesciences